/Catalent%20Inc_%20HQ%20in%20New%20Jersey-by%20JHVEPhoto%20via%20Shutterstock.jpg)
With a market cap of $10.7 billion, Catalent, Inc. (CTLT) is a leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. Based in Somerset, New Jersey, the company offers comprehensive services across two main segments: Biologics and Pharma & Consumer Health.
Shares of the drug delivery technologies maker have outperformed the broader market over the past 52 weeks. CTLT stock has risen 47.8% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 30.1%. In 2024, shares of CTLT are up 31.3%, compared to SPX's 24.1% gain on a YTD basis.
